Parenteral Nutrition Market Size, Share, and Trends 2025 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Parenteral Nutrition Market 

5.1. COVID-19 Landscape: Parenteral Nutrition Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Parenteral Nutrition Market, By Nutrient Type

8.1. Parenteral Nutrition Market Revenue and Volume Forecast, by Nutrient Type

8.1.1. Carbohydrates

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Parenteral Lipid Emulsion

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Single Dose Amino Acid Solution

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Trace Elements

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Vitamins & Minerals

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. Global Parenteral Nutrition Market, By Stage Type

9.1. Parenteral Nutrition Market Revenue and Volume Forecast, by Stage Type

9.1.1. Adult

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Pediatrics

9.1.2.1. Market Revenue and Volume Forecast

Chapter 10. Global Parenteral Nutrition Market, By Indication 

10.1. Parenteral Nutrition Market Revenue and Volume Forecast, by Indication

10.1.1. Alzheimer’s

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Nutrition Deficiency

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Cancer Care

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Chronic Kidney Diseases

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Orphan Diseases

10.1.5.1. Market Revenue and Volume Forecast

10.1.6. Dysphagia

10.1.6.1. Market Revenue and Volume Forecast

10.1.7. Pain Management

10.1.7.1. Market Revenue and Volume Forecast

10.1.8. Malabsorption/GI Disorder/Diarrhea

10.1.8.1. Market Revenue and Volume Forecast

10.1.9. Others

10.1.9.1. Market Revenue and Volume Forecast

Chapter 11. Global Parenteral Nutrition Market, By Sales Channel 

11.1. Parenteral Nutrition Market Revenue and Volume Forecast, by Sales Channel

11.1.1. Online Sales

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Retail Sales

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Institutional Sales

11.1.3.1. Market Revenue and Volume Forecast

Chapter 12. Global Parenteral Nutrition Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Nutrient Type

12.1.2. Market Revenue and Volume Forecast, by Stage Type

12.1.3. Market Revenue and Volume Forecast, by Indication

12.1.4. Market Revenue and Volume Forecast, by Sales Channel

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Nutrient Type

12.1.5.2. Market Revenue and Volume Forecast, by Stage Type

12.1.5.3. Market Revenue and Volume Forecast, by Indication

12.1.5.4. Market Revenue and Volume Forecast, by Sales Channel

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Nutrient Type

12.1.6.2. Market Revenue and Volume Forecast, by Stage Type

12.1.6.3. Market Revenue and Volume Forecast, by Indication

12.1.6.4. Market Revenue and Volume Forecast, by Sales Channel

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Nutrient Type

12.2.2. Market Revenue and Volume Forecast, by Stage Type

12.2.3. Market Revenue and Volume Forecast, by Indication

12.2.4. Market Revenue and Volume Forecast, by Sales Channel

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Nutrient Type

12.2.5.2. Market Revenue and Volume Forecast, by Stage Type

12.2.5.3. Market Revenue and Volume Forecast, by Indication

12.2.5.4. Market Revenue and Volume Forecast, by Sales Channel

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Nutrient Type

12.2.6.2. Market Revenue and Volume Forecast, by Stage Type

12.2.6.3. Market Revenue and Volume Forecast, by Indication

12.2.6.4. Market Revenue and Volume Forecast, by Sales Channel

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Nutrient Type

12.2.7.2. Market Revenue and Volume Forecast, by Stage Type

12.2.7.3. Market Revenue and Volume Forecast, by Indication

12.2.7.4. Market Revenue and Volume Forecast, by Sales Channel

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Nutrient Type

12.2.8.2. Market Revenue and Volume Forecast, by Stage Type

12.2.8.3. Market Revenue and Volume Forecast, by Indication

12.2.8.4. Market Revenue and Volume Forecast, by Sales Channel

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Nutrient Type

12.3.2. Market Revenue and Volume Forecast, by Stage Type

12.3.3. Market Revenue and Volume Forecast, by Indication

12.3.4. Market Revenue and Volume Forecast, by Sales Channel

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Nutrient Type

12.3.5.2. Market Revenue and Volume Forecast, by Stage Type

12.3.5.3. Market Revenue and Volume Forecast, by Indication

12.3.5.4. Market Revenue and Volume Forecast, by Sales Channel

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Nutrient Type

12.3.6.2. Market Revenue and Volume Forecast, by Stage Type

12.3.6.3. Market Revenue and Volume Forecast, by Indication

12.3.6.4. Market Revenue and Volume Forecast, by Sales Channel

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Nutrient Type

12.3.7.2. Market Revenue and Volume Forecast, by Stage Type

12.3.7.3. Market Revenue and Volume Forecast, by Indication

12.3.7.4. Market Revenue and Volume Forecast, by Sales Channel

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Nutrient Type

12.3.8.2. Market Revenue and Volume Forecast, by Stage Type

12.3.8.3. Market Revenue and Volume Forecast, by Indication

12.3.8.4. Market Revenue and Volume Forecast, by Sales Channel

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Nutrient Type

12.4.2. Market Revenue and Volume Forecast, by Stage Type

12.4.3. Market Revenue and Volume Forecast, by Indication

12.4.4. Market Revenue and Volume Forecast, by Sales Channel

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Nutrient Type

12.4.5.2. Market Revenue and Volume Forecast, by Stage Type

12.4.5.3. Market Revenue and Volume Forecast, by Indication

12.4.5.4. Market Revenue and Volume Forecast, by Sales Channel

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Nutrient Type

12.4.6.2. Market Revenue and Volume Forecast, by Stage Type

12.4.6.3. Market Revenue and Volume Forecast, by Indication

12.4.6.4. Market Revenue and Volume Forecast, by Sales Channel

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Nutrient Type

12.4.7.2. Market Revenue and Volume Forecast, by Stage Type

12.4.7.3. Market Revenue and Volume Forecast, by Indication

12.4.7.4. Market Revenue and Volume Forecast, by Sales Channel

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Nutrient Type

12.4.8.2. Market Revenue and Volume Forecast, by Stage Type

12.4.8.3. Market Revenue and Volume Forecast, by Indication

12.4.8.4. Market Revenue and Volume Forecast, by Sales Channel

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Nutrient Type

12.5.2. Market Revenue and Volume Forecast, by Stage Type

12.5.3. Market Revenue and Volume Forecast, by Indication

12.5.4. Market Revenue and Volume Forecast, by Sales Channel

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Nutrient Type

12.5.5.2. Market Revenue and Volume Forecast, by Stage Type

12.5.5.3. Market Revenue and Volume Forecast, by Indication

12.5.5.4. Market Revenue and Volume Forecast, by Sales Channel

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Nutrient Type

12.5.6.2. Market Revenue and Volume Forecast, by Stage Type

12.5.6.3. Market Revenue and Volume Forecast, by Indication

12.5.6.4. Market Revenue and Volume Forecast, by Sales Channel

Chapter 13. Company Profiles

13.1. Baxter

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Allergan

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Actavis Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Otsuka Pharmaceutical Factory, Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Grifols, S.A.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. B. Braun Melsungen AG

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Vifor Pharma

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Fresenius Kabi AG

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Sichuan Kelun Pharmaceutical Co., Ltd.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Pfizer Inc. (Hospira Inc.)

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms